MAX - SHOCK Clinical Trial

Clinical trial NCT06556667 · RECRUITING

Trial details

NCT number: NCT06556667
Sponsor: Ottawa Heart Institute Research Corporation
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Cardioversion Atrial Fibrillation

Start date: 2025-03-31
Primary completion: 2027-09-01
Enrollment: 376

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.